Clinical Trial Update: A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and tolerability study of NC410 in advanced or metastatic solid tumors has been terminated, with results posted in 2024, including ovarian, gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Ovarian Cancer

Drugs mentioned

• NC410

Snippet

Sponsor: NextCure, Inc. | Conditions: Advanced or Metastatic Solid Tumors, Ovarian Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-07-25